Germline p53 single-base changes associated with Balkan endemic nephropathy

Biochemical and Biophysical Research Communications

Volumn 342, Issue 2, 2006, Pages 562-567

  Krasteva, Maria Emileva ^a   Georgieva, Elena Ivanova ^a  

^a INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Balkan endemic nephropathy; Cancer; Mutation; p53; PCR SSCP; Tumor suppressor genes

Indexed keywords

PROTEIN P53;

ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; CANCER; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; INTERSTITIAL NEPHRITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCREENING; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AMINO ACID SUBSTITUTION; BALKAN NEPHROPATHY; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 33644538925     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.004     Document Type: Article

References (38)

1. M. Radonic, and Z. Radosevic Clinical features of Balkan endemic nephropathy Food Chem. Toxicol. 30 1992 189 192
2. I.N. Chernozemsky, I.S. Stoyanov, T.K. Petkova-Bocharova, I.G. Nicolov, I.V. Draganov, I.I. Stoichev, Y. Tanchev, D. Naidenov, and N.D. Kalcheva Geographic correlation between the occurrence of endemic nephropathy and urinary tract tumours in Vratza district, Bulgaria Int. J. Cancer 19 1977 1 11
3. R. Cukuranovic, M. Ignjatovic, and V. Stefanovic Urinary tract tumors and Balkan nephropathy in the South Morava River basin Kidney Int. 40 1991 80 84
4. Z. Bozic, V. Duancic, M. Belicza, O. Kraus, and I. Skljarov Balkan endemic nephropathy: still a mysterious disease Eur. J. Epidemiol. 11 1995 235 238
5. P.H. Bach, N.J. Cregg, and L. Delacruz Relevance of rat model papillary necrosis and upper urothelial carcinoma in understanding the role of ochratoxine A in Balkan endemic nephropathy and its associated carcinoma Food Chem. Toxicol. 4 1992 205
6. G.L. Feder, Z. Radovanovic, and R.B. Finkelman Relationship between weathered coal deposits and the etiology of Balkan endemic nephropathy Kidney Int. 40 1991 9 11
7. J.P. Cosyns, M. Jadoul, and J.P. Squifflet Chinese herbs nephropathy: a clue to Balkan endemic nephropathy? Kidney Int. 45 1994 1680 1688
8. R.P. Wedeen Environmental renal-disease-lead, cadmium and Balkan endemic nephropathy Kidney Int. 40 1991 4 8
9. D. Toncheva, T.z. Dimitrov, and M. Tzoneva Cytogenetic studies in Balkan endemic nephropathy Nephron 48 1988 18 21
10. D.I. Toncheva, S.Y. Atanassova, T.D. Gergov, E.G. Todorovska, I.G. Roeva, T.H. Georgiev, J. Fink-Gremmels, and B.M. Zaharieva Genetic changes in uroepithelial tumors of patients with Balkan endemic nephropathy J. Nephrol. 15 2002 387 393
11. J.C. Ritchie, M.J. Crothers, J.R. Idle, J.B. Greig, T.A. Connors, I.G. Nikolov, and I.N. Chernozemsky Evidence for an inherited metabolic susceptibility to endemic (Balkan) nephropathy S. Strahinjic V. Stefanovic Current Research in Endemic (Balkan) Nephropathy 1983 University Press 23 27
12. N.M. Pavlovic, Z. Vargheze, J.W. Persaud, V. Stefanovic, S. Strahinjic, V. Savic, and J.F. Moorhead Partial lecithin cholesterol acyltransferase (LCAT) deficiency in Balkan endemic nephropathy Kidney Int. 40 1991 102 105
13. I. Andonova, R. Sarueva, A. Horvath, V. Simeonov, P. Dimitrov, E. Petropoulos, and V. Ganev Balkan endemic nephropathy and genetic variants of glutathione S-transferases J. Nephrol. 17 2004 390 398
14. D. Malkin The role of P53 in human cancer J. Neurooncol. 51 2001 231 243
15. C. Miller, T. Mohandas, D. Wolf, M. Prokocimer, V. Rotter, and H.P. Koeffler Human p53 localized to short arm of chromosome 17 Nature 319 1986 783 784
16. V. Petronic, and M. Savin Apoptosis and p53 status of upper urothelial carcinomas from Balkan endemic nephropathy regions Nephrol. Dial. Transpl. 16 2001 33 35
17. N.N. Ahmad, A.B. Cu-Unjieng, and L.A. Donoso Modification of standard proteinase-K/phenol method for DNA isolation to improve yield and purity from frozen blood J. Med. Genet. 32 1995 129 130
18. M.E. Krasteva, Z. Garanina, and E.I. Georgieva Optimized polymerase chain reaction-based single-strand conformation polymorphism analysis of p53 gene applied to Bulgarian patients with invasive breast cancer Clin. Exp. Med. 3 2003 173 180
19. G. Deng, L.-C. Chen, D.R. Schott, A. Thor, V. Bhargava, B.-M. Ljung, K. Chew, and H.S. Smith Loss of heterozygosity and p53 gene mutations in breast cancer Cancer Res. 54 1994 499 505
20. A. Kannio, M. Ridenpaa, H. Koskinen, T. Partenen, S. Anttila, Y. Collan, E. Hietanen, H. Vaino, and K. Husgafvel-Pursiainen A molecular and epidemiological study on bladder cancer: p53 mutations, tobacco smoking and occupational exposure to abestos Cancer Epidemiol. Biomarkers Prev. 5 1996 33 39
21. J.L. Prescott, J. Montie, T.W. Pugh, T. McHugh, and R.W. Veltri Clinical sensitivity of p53 mutation detection in matched bladder tumor, bladder wash, and voided urine specimens Cancer 91 2001 2127 2135
22. K. Angelopoulou, H. Yu, B. Bharaj, M. Giai, and E.P. Diamandis p53 gene mutation, tumor p53 protein overexpression, and serum p53 autoantibody generation in patients with breast cancer Clin. Biochem. 33 2000 53 62
23. K. Conway, S.N. Edmiston, L. Cui, S.S. Drouin, J. Pang, M. He, C.K. Tse, J. Geradts, L. Dressler, E.T. Liu, R. Millikan, and B. Newman Prevalence and spectrum of p53 mutations associated with smoking in breast cancer Cancer Res. 62 2002 1987 1995
24. M.A. Peidano, M. Fernandez-Renart, G. Capella, L. Wilson, and M. Perucho Mutations in the p53 suppressor gene do not correlate with c-K-ras oncogene mutations in colorectal cancer Int. J. Oncol. 2 1993 123 134
25. S.J. Baker, A.C. Preisinger, J.M. Jessup, C. Paraskeva, S. Markowitz, J.K.V. Willson, S. Hamilton, and B. Vogelstein p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis Cancer Res. 50 1990 7717 7722
26. M. Rugge, Y.H. Shiao, G. Busatto, M. Cassaro, C. Strobbe, V.M. Russo, G. Leo, A.R. Parenti, A. Scapinello, P. Arslan, and E. Egarter-Vigl The p53 gene in patients under the age of 40 with gastric cancer: mutation rates are low but are associated with a cardiac location Mol. Pathol. 53 2000 207 210
27. R. Deguchi, A. Takagi, H. Kawata, H. Inoko, and T. Miwa Association between CagA+ Helicobacter pylori infection and p53, bax and transforming growth factor-beta-RII gene mutations in gastric cancer patients Int. J. Cancer 91 2001 481 485
28. N.S. Agar, G.M. Halliday, R.S. Barnetson, H.N. Ananthaswamy, M. Wheeler, and A.M. Jones The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis Proc. Natl. Acad. Sci. USA 101 2004 4954 4959
29. Y. Yamanishi, D.L. Boyle, D.R. Green, E.C. Keystone, A. Connor, S. Zollman, and G.S. Firestein p53 tumor suppressor gene mutations in fibroblast-like synoviocytes from erosion synovium and non-erosion synovium in rheumatoid arthritis Arthritis Res. Ther. 7 2005 12 18
30. E. Kucera, P. Speiser, M. Gnant, L. Szabo, H. Samonigg, H. Hausmaninger, M. Mittlbock, M. Fridrik, M. Seifert, E. Kubista, A. Reiner, R. Zeillinger, and R. Jakesz Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients Eur. J. Cancer 35 1999 398 405
31. R.K. Dang, R.S. Anthony, J.I. Craig, R.C. Leonard, and A.C. Parker Limitations of the use of single base changes in the p53 gene to detect minimal residual disease of breast cancer Mol. Pathol. 55 2002 177 181
32. I. Albanese, A.G. Scibetta, M. Migliavacca, A. Russo, V. Bazan, R.M. Tomasino, P. Colomba, M. Tagliavia, and M. La Farina Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations Biochem. Biophys. Res. Commun. 325 2004 784 791
33. D. Graziani, S. Romagnoli, B. Cassani, R.M. Alfano, M. Roncalli, and G. Coggi An Ava I polymorphism in the TP53 gene Mol. Cell Probes 13 1999 393 395
34. T. Lehman, B. Haffty, C. Carbone, L. Bishop, A. Gumbs, S. Krishnan, P. Shields, R. Modali, and B. Turner Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer Cancer Res. 60 2000 1062 1069
35. J.L. Soto, C.M. Cabrera, S. Serrano, and M.A. Lopez-Nevot Mutation analysis of genes that control the G1/S cell cycle in melanoma: TP53, CDKN1A, CDKN2A, and CDKN2B BMC Cancer 5 2005 36 44
36. D. Mavridou, R. Gornall, I.G. Campbell, and D.M. Eccles TP53 intron 6 polymorphism and the risk of ovarian and breast cancer Br. J. Cancer 77 1998 676 677
37. A. Sjalander, R. Birgander, L. Athlin, R. Stenling, J. Rutegard, L. Beckman, and G. Beckman p53 germline haplotypes associated with increased risk for colorectal cancer Carcinogenesis 16 1995 1461 1464
38. D. Malkin p53 and the Li-Fraumeni syndrome Cancer Genet. Cytogenet. 66 1993 83 92